Because the major hypothesis suggests that in chronic hyperinsulinemia, insulin competes with Aβ for IDE binding, impairing Aβ clearance and promoting its accumulation in the brain, although this mechanism is well supported by preclinical data, it remains difficult to quantify directly in human studies. The gene discussed is INS; the disease is hyperinsulinism.